Literature DB >> 3490873

Lymphocyte markers and clinical expression of lymphoproliferative disorders with moderate lymphocytosis.

J Economidou, H Choremi, N Konstantinidou, A Kofina, K Psarra, K Stefanoudaki, A Papayannis, F Economopoulos, J Dervenoulas, J Vlachos.   

Abstract

Lymphoproliferative syndrome with well differentiated lymphocytes and moderate lymphocytosis in the peripheral blood includes a heterogeneous group of disorders, that present often difficulties in classification. We have studied the lymphocyte markers (ER, EMR, sIg and T3, T4, T8 antigens) in 36 cases who had lymphocytic infiltration in the bone marrow and peripheral lymphocyte counts less than 15 X 10(9) l-1. Four cases (11.1%) had the characteristics of T8 lymphocytosis and 31 had a B cell monoclonal proliferation in the peripheral blood. Of these, four were sIg-, EMR+, 19 were sIg+, EMR+ and 8 were sIg+, EMR-. Most patients (17/32) had the clinical picture of stage 0 and I B-CLL. Six cases presented as pure splenomegalic form of CLL, three had the features of immunocytic lymphoma and five had the features of lymphocytic lymphoma. It is concluded that the majority of lymphoproliferative disorders presenting with moderate lymphocytosis represent early forms of B-CLL. Occasionally cases of lymphocytic or immunocytic lymphoma may present problems of differential diagnosis since there may be a dissociation of phenotypic characteristics of lymphocytes between tissues and peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490873      PMCID: PMC2001497          DOI: 10.1038/bjc.1986.222

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Clinical staging of chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

2.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

3.  Phenotypes in chronic B-lymphocytic leukemia probed by monoclonal antibodies and immunoglobulin secretion studies: identification of stages of maturation arrest and the relation to clinical findings.

Authors:  J Gordon; H Mellstedt; P Aman; P Biberfeld; M Björkholm; G Klein
Journal:  Blood       Date:  1983-10       Impact factor: 22.113

4.  Mouse RBC rosettes in chronic lymphocytic leukaemia: different expression in blood and tissues.

Authors:  M Cherchi; D Catovsky
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

Review 5.  Clinical patterns in B lymphoid malignancy.

Authors:  D A Galton; I C MacLennan
Journal:  Clin Haematol       Date:  1982-10

Review 6.  The differentiation and function of human T lymphocytes.

Authors:  E L Reinherz; S F Schlossman
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

7.  Mouse red-cell rosettes in B-lymphoproliferative disorders.

Authors:  D Catovsky; M Cherchi; A Okos; U Hegde; D A Galton
Journal:  Br J Haematol       Date:  1976-06       Impact factor: 6.998

8.  Immunoglobulin abnormalities in malignant non-Hodgkin's lymphoma.

Authors:  J Economidou; K Terzoglou; D Anagnostou; E M Nikiforakis; A Papajannis
Journal:  Scand J Haematol       Date:  1984-08

9.  T8 chronic lymphocytic leukemia. A distinctive disorder related to T8 lymphocytosis.

Authors:  J U Brisbane; L D Berman; M E Osband; R S Neiman
Journal:  Am J Clin Pathol       Date:  1983-09       Impact factor: 2.493

10.  Rosette formation with mouse erythrocytes. III. Studies in patients with primary immunodeficiency and lymphoproliferative disorders.

Authors:  S Gupta; R A Good; F P Siegal
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.